| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
K.EGNGTVMGAELR.H 3.57 3.71 617.3035 54.26 - 63.76 2 1.3E6 58.07 99 110 N
R.ALGQNPVNAEVLK.V Y 4.51 3.67 676.8844 70.89 - 76.31 2 5.5E5 73.09 38 50 Y
K.EAFLLFDR.T Y 4.19 2.02 505.7716 118.14 - 121.91 2 3.6E5 119.68 14 21 Y
R.HVLTTLGEK.M 3.50 4.09 499.2911 40.08 - 49.97 2 3E5 43.63 111 119 N
K.AEEMNLK.M 2.60 1.85 417.7094 36.43 - 45.60 2 2.6E5 39.30 57 63 N
K.ISFSQCGDVMR.A Y 3.02 0.65 621.7896 84.35 - 88.98 2 1.8E5 86.17 27 37 Y
K.NKDQGSMEDFVEGLR.V Y 3.47 1.97 575.6061 96.66 - 101.32 3 1.8E5 98.54 80 94 N
R.VFDKEGNGTVMGAELR.H 2.40 2.08 574.9582 67.00 - 72.74 3 1.5E5 69.50 95 110 N
R.MVMNG 1.92 1.86 551.2374 35.20 - 44.27 1 1.5E5 37.76 147 151 N
M.S(+42.01)DFSEDQILEFK.E Y 2.37 1.77 750.3543 123.75 - 127.88 2 1.4E5 125.18 2 13 N Acetylation (Protein N-term)
K.VLGNPK.A 2.07 0.11 314.1960 28.73 - 32.98 2 1.1E5 30.12 51 56 N
K.DQGSMEDFVEGLR.V Y 2.34 0.88 741.8347 112.31 - 116.81 2 1E5 114.20 82 94 N
K.ISFSQC(+57.02)GDVMR.A Y 2.19 2.99 650.2985 70.41 - 75.99 2 8.6E4 72.76 27 37 N Carbamidomethylation
K.I(+43.01)SFSQCGDVMR.A Y 2.24 0.70 643.2912 74.82 - 80.62 2 7E4 77.10 27 37 N Carbamylation
K.AEEMNLK.M 2.00 0.71 834.4075 36.40 - 45.63 1 4.8E4 39.32 57 63 N
R.H(+43.01)VLTTLGEK.M 2.42 0.66 520.7946 64.08 - 70.69 2 4.8E4 66.77 111 119 N Carbamylation
K.NKDQGSMEDFVEGLR.V Y 2.20 1.47 862.9043 95.05 - 101.29 2 4.2E4 98.46 80 94 N
K.VLGNPK.A 2.31 0.78 627.3862 28.90 - 33.09 1 3.9E4 30.12 51 56 N
K.E(-18.01)GNGTVM(+15.99)GAELR.H 0.44 0.59 616.3036 54.85 - 61.37 2 3.2E4 58.38 99 110 N Pyro-glu from E; Oxidation (M)
R.VFDKEGNGTVMGAELR.H 1.50 1.63 861.9324 67.17 - 71.66 2 3.2E4 69.31 95 110 N
K.ISFSQCGDVMR.A Y 0.04 5.54 621.7781 86.19 - 87.74 2 2.2E4 86.73 27 37 N
K.EAFLLFDR.T Y 1.95 1.11 1010.5341 118.22 - 121.78 1 1.6E4 119.68 14 21 N
K.DQGSMEDFVEGLR.V Y 1.97 0.38 494.8922 112.80 - 115.97 3 1.5E4 114.21 82 94 N
R.MVMNG 0.03 5.27 551.2268 36.53 - 38.53 1 1.4E4 37.04 147 151 N
K.MSEEEVETLLAGHEDANGCINYEELVR.M Y 1.38 0.84 1017.4673 128.10 - 129.83 3 1.3E4 128.65 120 146 N
R.A(+43.01)LGQNPVNAEVLK.V Y 1.04 0.40 698.3866 93.53 - 96.74 2 1.2E4 94.95 38 50 N Carbamylation
K.N(+43.01)KDQGSMEDFVEGLR.V Y 0.74 0.52 884.4123 108.43 - 114.17 2 1.1E4 111.36 80 94 N Carbamylation
K.EGNGTVMGAELR.H 0.01 0.49 617.3114 57.44 - 59.94 2 9.8E3 58.53 99 110 N
K.EGNGT(-18.01)VMGAELR.H 0.26 0.47 608.2972 71.73 - 77.49 2 9.8E3 73.37 99 110 N Phospho neutral loss (ST)
R.ALGQNPVNAEVLK.V Y 0.63 0.90 451.5906 72.06 - 76.09 3 8.2E3 73.34 38 50 N
M.S(+43.01)DFSEDQILEFK.E Y 0.42 0.13 750.8488 122.53 - 126.60 2 8.1E3 123.76 2 13 N Carbamylation
M.S(+43.01)DFSEDQILEFK.E Y 0.16 3.10 750.8573 122.58 - 128.11 2 6.6E3 125.81 2 13 N Carbamylation
K.E(-18.01)AFLLFDR.T Y 1.34 1.00 496.7663 118.12 - 121.62 2 4.7E3 119.71 14 21 N Pyro-glu from E
K.VLGNPK.A 0.08 0.36 314.1928 29.28 - 33.55 2 4.6E3 31.46 51 56 N
K.N(+43.01)KDQGSMEDFVEGLR.V Y 0.10 2.38 884.4142 107.68 - 110.52 2 4.4E3 109.29 80 94 N Carbamylation
K.N(+43.01)KDQGSMEDFVEGLR.V Y 0.23 0.55 589.9453 107.72 - 109.98 3 4.3E3 109.11 80 94 N Carbamylation
K.E(+43.01)GNGTVMGAELR.H 0.02 5.20 638.7970 71.27 - 73.74 2 2.4E3 72.67 99 110 N Carbamylation
M.S(+42.01)DFSEDQILEFK.E Y 0.06 0.42 750.3642 123.18 - 127.48 2 1.9E3 125.71 2 13 N Acetylation (Protein N-term)
K.E(+43.01)AFLLFDR.T Y 1.27 0.07 527.2745 134.19 - 135.19 2 1.7E3 134.58 14 21 N Carbamylation
K.VLGNPK.A 0.01 0.07 314.1935 30.94 - 35.20 2 1.2E3 32.36 51 56 N
K.EAFLLFDR.T Y 0.06 4.39 1010.5234 119.12 - 121.78 1 268.5 120.26 14 21 N
total 41 peptides